Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity

Elias Toubi(Bnai Zion Medical Center), E. Zuckerman(Bnai Zion Medical Center), Michael Rozenbaum(Bnai Zion Medical Center), Itzhak Rosner(Bnai Zion Medical Center), Stuart C. Gordon(United States Department of Veterans Affairs), Aharon Kessel(Technion – Israel Institute of Technology), Y Shoenfeld(Tel Aviv University)
Journal of Autoimmunity
September 1, 2006
10.1016/j.jaut.2006.07.005
Cited by 117

Related Papers

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k